{
  "schema_version": "0.4",
  "ir_kind": "hl",
  "metadata": {
    "title": "Establish organoid system with eCas9 and Cre recombinase",
    "source": {
      "type": "paper",
      "id": "s41586-023-06473-y.pdf"
    }
  },
  "resources": {
    "materials": [],
    "containers": [],
    "equipment": [],
    "samples": [],
    "data": []
  },
  "protocol": {
    "steps": [
      {
        "id": "s1",
        "op": "annotate",
        "inputs": [],
        "outputs": [],
        "params": {},
        "annotations": {
          "text": "To establish an organoid system that enables CRISPR perturbations with single-cell transcriptomic readout, we used a human embryonic stem cell (hES cell) line expressing an enhanced specificity SpCas9 (eCas9), which has substantially reduced off-target effects and is controlled by an upstream loxp stop element12 (Fig. 1a)."
        }
      },
      {
        "id": "s2",
        "op": "annotate",
        "inputs": [],
        "outputs": [],
        "params": {},
        "annotations": {
          "text": "To regulate eCas9 induction, we engineered a lentiviral vector to deliver 4-hydroxytamoxifen-inducible CRE recombinase and a dual single-guide RNA (sgRNA) cassette (Fig. 1a)."
        }
      }
    ],
    "start_step_id": "s1",
    "edges": [
      {
        "from": "s1",
        "to": "s2"
      }
    ],
    "detail_level": 0
  }
}